Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors
- PMID: 16819324
- DOI: 10.1097/01.pas.0000213250.44822.2e
Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors
Abstract
Combined loss of heterozygosity (LOH) on 1p and 19q is reported in 50% to 90% of oligodendroglial tumors and has emerged as a strong and favorable prognostic factor. Fluorescence in situ hybridization (FISH) and polymerase chain reaction (PCR) are the most widely used techniques. The aim of this study was to evaluate the reliability of FISH to predict LOH at 1p and 19q when performed on touch preparations from 40 oligodendroglial tumors, even if the majority of the nuclei showed chromosomal imbalance. PCR was used as the gold standard. The presence of none or one target signal was reported as FISH-LOH, whereas all other losses were defined as FISH-imbalance. The sum of nuclei with FISH-LOH and imbalance was calculated in each case (FISH-sum) and cut-off values were defined as the mean FISH-sum value in controls plus 3 standard deviations; 27.7% for 1p and 33.2% for 19q. These corresponded well with the optimal cut-off values for our data, calculated using the minimum error rate classification procedure (35.6% for 1p and 33.1% for 19q). Concurrent FISH and PCR results were encountered in 95% for 1p and 87.5% for 19q. FISH-sum was the best and simplest discriminating variable for correct classification of LOH status. Under these conditions, even a dominant population of nuclei showing FISH-imbalance represented an LOH status in the tumor cells. FISH on touch preparations is a quick and reliable method for 1p/19q testing, does not require normal DNA and can be easily performed in an immunohistochemistry unit.
Similar articles
-
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.Clin Cancer Res. 2005 Feb 1;11(3):1119-28. Clin Cancer Res. 2005. PMID: 15709179
-
Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens.Mod Pathol. 2003 Jul;16(7):708-15. doi: 10.1097/01.MP.0000076981.90281.BF. Mod Pathol. 2003. PMID: 12861068
-
The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors.Cancer. 2005 Oct 1;104(7):1468-77. doi: 10.1002/cncr.21338. Cancer. 2005. PMID: 16088966
-
Analysis of genomic imprinting at 1p35-36 in neuroblastoma.Med Pediatr Oncol. 2001 Jan;36(1):52-5. doi: 10.1002/1096-911X(20010101)36:1<52::AID-MPO1014>3.0.CO;2-8. Med Pediatr Oncol. 2001. PMID: 11464906 Review.
-
[The oligodendroglioma: the value of histologic and genetic diagnosis in predicting sensitivity to chemotherapy].Ned Tijdschr Geneeskd. 2005 Jun 18;149(25):1379-85. Ned Tijdschr Geneeskd. 2005. PMID: 15997690 Review. Dutch.
Cited by
-
Artificial Intelligence in the Management of Glioma: Era of Personalized Medicine.Front Oncol. 2019 Aug 14;9:768. doi: 10.3389/fonc.2019.00768. eCollection 2019. Front Oncol. 2019. PMID: 31475111 Free PMC article. Review.
-
Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta-analysis based on a Cochrane systematic review.Neuropathol Appl Neurobiol. 2022 Jun;48(4):e12790. doi: 10.1111/nan.12790. Epub 2022 Mar 3. Neuropathol Appl Neurobiol. 2022. PMID: 34958131 Free PMC article.
-
[Fluorescence in situ hybridization. A new diagnostic dimension in cytology].Pathologe. 2007 Sep;28(5):384-92. doi: 10.1007/s00292-007-0930-x. Pathologe. 2007. PMID: 17661041 German.
-
Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas.J Neurooncol. 2008 Jul;88(3):293-8. doi: 10.1007/s11060-008-9563-z. Epub 2008 Mar 15. J Neurooncol. 2008. PMID: 18345516
-
Can artificial intelligence overtake human intelligence on the bumpy road towards glioma therapy?Med Oncol. 2021 Apr 3;38(5):53. doi: 10.1007/s12032-021-01500-2. Med Oncol. 2021. PMID: 33811540 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources